Inventor
WHITESITT CELIA A
US20 patents
⚠️ This page may combine multiple inventors who share the name “WHITESITT CELIA A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
18 patentsUS5624937AApr 29, 1997
Chemical compounds as inhibitors of amyloid beta protein production
LILLY CO ELI182 citations99
US5612360AMar 18, 1997
Angiotensin II antagonists
LILLY CO ELI142 citations97
US5814646ASep 29, 1998
Inhibitors of amyloid beta-protein production
LILLY CO ELI73 citations95
US5073566ADec 17, 1991
Angiotensin ii antagonist 1,3-imidazoles and use thereas
LILLY CO ELI71 citations95
US6251928B1Jun 26, 2001
Treatment of alzheimer's disease employing inhibitors of cathepsin D
LILLY CO ELI16 citations92
US5747517AMay 5, 1998
Benzylidene rhodanines
LILLY CO ELI24 citations92
US5569768AOct 29, 1996
Angiotensin II antagonists
LILLY CO ELI32 citations91
US5693633ADec 2, 1997
Angiotensin II antagonists
LILLY CO ELI8 citations73
US4195021AMar 25, 1980
1,3-Disubstituted 2-azetidinone antibitotics
LILLY CO ELI7 citations73
US6194416B1Feb 27, 2001
Heterocyclic compounds and their use
LILLY CO ELI2 citations62
US6117883ASep 12, 2000
Heterocyclic compounds
LILLY CO ELI6 citations62
US5571925ANov 5, 1996
Angiotensin II antagonists
LILLY CO ELI1 citations62
US5563278AOct 8, 1996
Angiotensin II antagonists
LILLY CO ELI3 citations62
US5312936AMay 17, 1994
Angiotensin II antagonists
LILLY CO ELI3 citations62
US4777298AOct 11, 1988
Process for intermediates to leukotriene antagonists
LILLY CO ELI5 citations62
US4820723AApr 11, 1989
Disubstituted tetrazole leukotriene antagonists and methods for their use thereas
LILLY CO ELI0 citations51
US4777299AOct 11, 1988
Process for leukotriene antagonists
LILLY CO ELI1 citations51
US6124312ASep 26, 2000
Heterocyclic compounds
LILLY CO ELI1 citations50
ATHENA NEUROSCIENCES INC
2 patentsUS5965614AOct 12, 1999
N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC6 citations74
US6399628B1Jun 4, 2002
N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds
ATHENA NEUROSCIENCES INC2 citations63